Comments
Loading...

CARISMA Therapeutics

CARMNASDAQ
Logo brought to you by Benzinga Data
$0.4407
-0.02-3.46%
At close: -
$0.4309
-0.00980-2.22%
After Hours: 5:42 PM EDT

CARISMA Therapeutics (NASDAQ:CARM) Stock Quotes, Forecast and News Summary

CARISMA Therapeutics Stock (NASDAQ: CARM) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Oct 24
4
Nov 24
2
3
Dec 24
2
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$0.47
Close$0.44
Volume / Avg.162.82K / 261.09K
Day Range$0.44 - $0.48
52 Wk Range0.38 - 2.77
Market Cap$17.99M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
37
Short Interest
1.61%
Days to Cover1.34

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CARM
NKGN

FAQ

Q

How do I buy CARISMA Therapeutics (CARM) stock?

A

You can purchase shares of CARISMA Therapeutics (NASDAQ:CARM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are CARISMA Therapeutics (CARM) competitors?

Q

What is the forecast, or price target, for CARISMA Therapeutics (CARM) stock?

A

CARISMA Therapeutics has a consensus price target of $9.54.

Q

What is the current price for CARISMA Therapeutics (CARM)?

A

The stock price for CARISMA Therapeutics (NASDAQ: CARM) is $0.4309 last updated January 17, 2025 at 5:42 PM EST.

Q

Does CARISMA Therapeutics (CARM) pay a dividend?

A

There are no upcoming dividends for CARISMA Therapeutics.

Q

When is CARISMA Therapeutics (NASDAQ:CARM) reporting earnings?

A

CARISMA Therapeutics’s Q4 earnings are confirmed for Monday, March 31, 2025.

Q

Is CARISMA Therapeutics (CARM) going to split?

A

There is no upcoming split for CARISMA Therapeutics.

Q

What sector and industry does CARISMA Therapeutics (CARM) operate in?

A

CARISMA Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch